A role for neutral sphingomyelinase activation in the inhibition of LPS action by phospholipid oxidation products

Journal of Lipid Research

Volumn 47, Issue 9, 2006, Pages 1967-1974

  Walton, Kimberly A ^a   Gugiu, Bogdan G ^b   Thomas, Miracle ^a   Basseri, Robert J ^a   Eliav, Daniel R ^a   Salomon, Robert G ^b   Berliner, Judith A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Ceramide; Endothelium; Lipopolysaccharide

Indexed keywords

1 PALMITOYL 2 ARACHIDONYLGLYCERO 3 PHOSPHATIDYLCHOLINE; 1 PALMITOYL 2 ARACHIDONYLGLYCERO 3 PHOSPHATIDYLETHANOLAMINE; CARBOHYDRATE DERIVATIVE; CAVEOLIN; CERAMIDE; GW 4869; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; PHOSPHOLIPID; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELIN PHOSPHODIESTERASE INHIBITOR; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; AORTA; ARTICLE; CAVEOLA; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME MECHANISM; HUMAN; HUMAN CELL; INHIBITION KINETICS; LIPID OXIDATION; LIPID RAFT; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

ACUTE-PHASE PROTEINS; ANTIGENS, CD14; CARRIER PROTEINS; CAVEOLINS; CELLS, CULTURED; CERAMIDES; ENDOTHELIAL CELLS; ENZYME ACTIVATION; ENZYME INHIBITORS; GLYCERYLPHOSPHORYLCHOLINE; HUMANS; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; OXIDATION-REDUCTION; PHOSPHATIDYLETHANOLAMINES; PHOSPHOLIPIDS; SIGNAL TRANSDUCTION; SPHINGOMYELIN PHOSPHODIESTERASE;

EID: 33748751198     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M600060-JLR200     Document Type: Article

References (37)

1. Berliner, J. A., and A. D. Watson. 2005. A role for oxidized phospholipids in atherosclerosis. N. Engl. J. Med. 353: 9-11.
2. Bochkov, V. N., and N. Leitinger. 2003. Anti-inflammatory properties of lipid oxidation products. J. Mol. Med. 81: 613-626.
3. Leitinger, N., T. R. Tyner, L. Oslund, C. Rizza, G. Subbanagounder, H. Lee, P. T. Shih, N. Mackman, G. Tigyi, M. C. Territo, et al. 1999. Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils. Proc. Natl. Acad. Sci. USA. 96: 12010-12015.
4. Walton, K. A., A. L. Cole, M. Yeh, G. Subbanagounder, S. R. Krutzik, R. L. Modlin, R. M. Lucas, J. Nakai, E. J. Smart, D. K. Vora, et al. 2003. Specific phospholipid oxidation products inhibit ligand activation of Toll-like receptors 4 and 2. Arterioscler. Thromb. Vasc. Biol. 23: 1197-1203.
5. Bochkov, V. N., A. Kadl, J. Huber, F. Gruber, B. R. Binder, and N. Leitinger. 2002. Protective role of phospholipid oxidation products in endotoxin-induced tissue damage. Nature. 419: 77-81.
6. Subbanagounder, G., N. Leitinger, D. C. Schwenke, J. W. Wong, H. Lee, C. Rizza, A. D. Watson, K. F. Faull, A. M. Fogelman, and J. A. Berliner. 2000. Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position. Arterioscler. Thromb. Vasc. Biol. 20: 2248-2254.
7. Wang, P. Y., R. L. Kitchens, and R. S. Munford. 1995. Bacterial lipopolysaccharide binds to CD14 in low-density domains of the monocyte-macrophage plasma membrane. J. Inflamm. 47: 126-137.
8. Triantafilou, M., K. Miyake, D. T. Golenbock, and K. Triantafilou. 2002. Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J. Cell Sci. 115: 2603-2611.
9. Triantafilou, M., S. Morath, A. Mackie, T. Hartung, and K. Triantafilou. 2004. Lateral diffusion of Toll-like receptors reveals that they are transiently confined within lipid rafts on the plasma membrane. J. Cell Sci. 117: 4007-4014.
10. Dunzendorfer, S., H. K. Lee, K. Soldau, and P. S. Tobias. 2004. Toll-like receptor 4 functions intracellularly in human coronary artery endothelial cells: roles of LBP and sCD14 in mediating LPS responses. FASEB J. 18: 1117-1119.
11. Escargueil-Blanc, I., N. Andrieu-Abadie, S. Caspar-Bauguil, R. Brossmer, T. Levade, A. Negre-Salvayre, and R. Salvayre. 1998. Apoptosis and activation of the sphingomyelin-ceramide pathway induced by oxidized low density lipoproteins are not causally related in ECV-304 endothelial cells. J. Biol. Chem. 273: 27389-27395.
12. Loidl, A., E. Sevcsik, G. Riesenhuber, H. P. Deigner, and A. Hermetter. 2003. Oxidized phospholipids in minimally modified low density lipoprotein induce apoptotic signaling via activation of acid sphingomyelinase in arterial smooth muscle cells. J. Biol. Chem. 278: 32921-32928.
13. Chatterjee, S., J. A. Berliner, G. G. Subbanagounder, A. K. Bhunia, and S. Koh. 2004. Identification of a biologically active component in minimally oxidized low density lipoprotein (MM-LDL) responsible for aortic smooth muscle cell proliferation. Glycoconj. J. 20: 331-338.
14. Watson, A. D., N. Leitinger, M. Navab, K. F. Faull, S. Horkko, J. L. Witztum, W. Palinski, D. Schwenke, R. G. Salomon, W. Sha, et al. 1997. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J. Biol. Chem. 272: 13597-13607.
15. Gugiu, B. G., and R. G. Salomon. 2003. Total syntheses of bioactive oxidized ethanolamine phospholipids. Org. Lett. 5: 2797-2799.
16. Subbanagounder, G., J. W. Wong, H. Lee, K. F. Faull, E. Miller, J. L. Witztum, and J. A. Berliner. 2002. Epoxyisoprostane and epoxycyclopentenone phospholipids regulate monocyte chemotactic protein-1 and interleukin-8 synthesis. Formation of these oxidized phospholipids in response to interleukin-1beta. J. Biol. Chem. 277: 7271-7281.
17. Kim, J. A., M. C. Territo, E. Wayner, T. M. Carlos, F. Parhami, C. W. Smith, M. E. Haberland, A. M. Fogelman, and J. A. Berliner. 1994. Partial characterization of leukocyte binding molecules on endothelial cells induced by minimally oxidized LDL. Arterioscler. Thromb. 14: 427-433.
18. Parton, R. G., and J. F. Hancock. 2001. Caveolin and Ras function. Methods Enzymol. 333: 172-183.
19. Yeh, M., A. L. Cole, J. Choi, Y. Liu, D. Tulchinsky, J. H. Qiao, M. C. Fishbein, A. N. Dooley, T. Hovnanian, K. Mouilleseaux, et al. 2004. Role for sterol regulatory element-binding protein in activation of endothelial cells by phospholipid oxidation products. Circ. Res. 95: 780-788.
20. Liebisch, G., W. Drobnik, M. Reil, B. Trumbach, R. Arnecke, B. Olgemoller, A. Roscher, and G. Schmitz. 1999. Quantitative measurement of different ceramide species from crude cellular extracts by electrospray ionization tandem mass spectrometry (ESI-MS/MS). J. Lipid Res. 40: 1539-1546.
21. Chung, S. W., B. Y. Kang, S. H. Kim, Y. K. Pak, D. Cho, G. Trinchieri, and T. S. Kim. 2000. Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-gamma and nuclear factor-kappa B. J. Biol. Chem. 275: 32681-32687.
22. Leitinger, N. 2003. Oxidized phospholipids as modulators of inflammation in atherosclerosis. Curr. Opin. Lipidol. 14: 421-430.
23. Marchesini, N., and Y. A. Hannun. 2004. Acid and neutral sphingomyelinases: roles and mechanisms of regulation. Biochem. Cell Biol. 82: 27-44.
24. Honda, H. M., N. Leitinger, M. Frankel, J. I. Goldhaber, R. Natarajan, J. L. Nadler, J. N. Weiss, and J. A. Berliner. 1999. Induction of monocyte binding to endothelial cells by MM-LDL: role of lipoxygenase metabolites. Arterioscler. Thromb. Vasc. Biol. 19: 680-686.
25. Ishikawa, K., M. Navab, N. Leitinger, A. M. Fogelman, and A. J. Lusis. 1997. Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. J. Clin. Invest. 100: 1209-1216.
26. Qiu, H., T. Edmunds, J. Baker-Malcolm, K. P. Karey, S. Estes, C. Schwarz, H. Hughes, and S. M. Van Patten. 2003. Activation of human acid sphingomyelinase through modification or deletion of C-terminal cysteine. J. Biol. Chem. 278: 32744-32752.
27. Joseph, C. K., S. D. Wright, W. G. Bornmann, J. T. Randolph, E. R. Kumar, R. Bittman, J. Liu, and R. N. Kolesnick. 1994. Bacterial lipopolysaccharide has structural similarity to ceramide and stimulates ceramide-activated protein kinase in myeloid cells. J. Biol. Chem. 269: 17606-17610.
28. Koide, N., T. Sugiyama, I. Mori, M. M. Mu, T. Yoshida, and T. Yokochi. 2003. C2-ceramide inhibits LPS-induced nitric oxide production in RAW 264.7 macrophage cells through down-regulating the activation of Akt. J. Endotoxin Res. 9: 85-90.
29. Knapp, K. M., and B. K. English. 2000. Ceramide-mediated stimulation of inducible nitric oxide synthase (iNOS) and tumor necrosis factor (TNF) accumulation in murine macrophages requires tyrosine kinase activity. J. Leukoc. Biol. 67: 735-741.
30. Hsu, Y. W., K. H. Chi, W. C. Huang, and W. W. Lin. 2001. Ceramide inhibits lipopolysaccharide-mediated nitric oxide synthase and cyclooxygenase-2 induction in macrophages: effects on protein kinases and transcription factors. J. Immunol. 166: 5388-5397.
31. Cho, Y. H., C. H. Lee, and S. G. Kim. 2003. Potentiation of lipopolysaccharide-inducible cyclooxygenase 2 expression by C2-ceramide via c-Jun N-terminal kinase-mediated activation of CCAAT/enhancer binding protein beta inmacrophages. Mol. Pharmacol. 63: 512-523.
32. Megha, and E. London. 2004. Ceramide selectively displaces cholesterol from ordered lipid domains (rafts): implications for lipid raft structure and function. J. Biol. Chem. 279: 9997-10004.
33. van Blitterswijk, W. J., A. H. van der Luit, R. J. Veldman, M. Verheij, and J. Borst. 2003. Ceramide: second messenger or modulator of membrane structure and dynamics? Biochem. J. 369: 199-211.
34. Pfeiffer, A., A. Bottcher, E. Orso, M. Kapinsky, P. Nagy, A. Bodnar, I. Spreitzer, G. Liebisch, W. Drobnik, K. Gempel, et al. 2001. Lipopolysaccharide and ceramide docking to CD14 provokes ligandspecific receptor clustering in rafts. Eur. J. Immunol. 31: 3153-3164.
35. Podrez, E. A., E. Poliakov, Z. Shen, R. Zhang, Y. Deng, M. Sun, P. J. Finton, L. Shan, M. Febbraio, D. P. Hajjar, et al. 2002. A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions. J. Biol. Chem. 277: 38517-38523.
36. Stuart, L. M., J. Deng, J. M. Silver, K. Takahashi, A. A. Tseng, E. J. Hennessy, R. A. Ezekowitz, and K. J. Moore. 2005. Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain. J. Cell Biol. 170: 477-485.
37. Bocharov, A. V., I. N. Baranova, T. G. Vishnyakova, A. T. Remaley, G. Csako, F. Thomas, A. P. Patterson, and T. L. Eggerman. 2004. Targeting of scavenger receptor class B type I by synthetic amphipathic alpha-helical- containing peptides blocks lipopolysaccharide (LPS) uptake and LPS-induced pro-inflammatory cytokine responses in THP-1 monocyte cells. J. Biol. Chem. 279: 36072-36082.